Ling Lin
6 Papers
9 Citations
Ling Lin is an academic researcher. The author has contributed to research in topics: Cancer & T cell. The author has an hindex of 4, co-authored 6 publications.
Chat about Author
Papers
m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer.
Yueshui Zhao,Qijie Zhao,Parham Jabbarzadeh Kaboli,Jing Shen,Mingxing Li,Xu Wu,Jianhua Yin,Hanyu Zhang,Yuanlin Wu,Ling Lin,Lingling Zhang,Lin Wan,Qinglian Wen,Xiang Li,Chi Hin Cho,Tao Yi,Jing Li,Zhangang Xiao +17 more
TL;DR: The dysregulation of m1A regulators in GI cancer and its signaling pathways is demonstrated for the first time and will contribute to the understanding of RNA modification in cancer.
172
Protective Role of γδ T Cells in Different Pathogen Infections and Its Potential Clinical Application.
Yueshui Zhao,Ling Lin,Zhangang Xiao,Mingxing Li,Xu Wu,Wanping Li,Xiaobing Li,Qijie Zhao,Yuanlin Wu,Hanyu Zhang,Jianhua Yin,Lingling Zhang,Chi Hin Cho,Jing Shen +13 more
TL;DR: Various subgroups of γδ T cells which can induce multiple immune responses or effective functions to fight against common pathogen infections, such as Mycobacterium tuberculosis, Listeria monocytogenes, influenza viruses, HIV, EBV, and HBV are focused on.
CD4+ T cells in obesity and obesity-associated diseases.
Yueshui Zhao,Ling Lin,Jing Li,Zhangang Xiao,Bo Chen,Lin Wan,Mingxing Li,Xu Wu,Chi Hin Cho,Jing Shen +9 more
TL;DR: The current understandings of the roles of CD4+ T cells in obesity and obesity-associated diseases, and the effects of adipocytes as antigen presenting cells on regulating CD4- T cell activity are focused on.
35
Molecular Markers of Regulatory T Cells in Cancer Immunotherapy with Special Focus on Acute Myeloid Leukemia (AML) - A Systematic Review.
Parham Jabbarzadeh Kaboli,Lingling Zhang,Shixin Xiang,Jing Shen,Mingxing Li,Yueshui Zhao,Xu Wu,Qijie Zhao,Hanyu Zhang,Ling Lin,Jianhua Yin,Yuanlin Wu,Lin Wan,Tao Yi,Xiang Li,Chi Hin Cho,Jing Li,Zhangang Xiao,Qinglian Wen +18 more
TL;DR: Treg cells are strongly increased in AML and the comparative review of key markers shows that Tregbased immunotherapy is not effective for all kinds of cancer, so blocking CD25(+)FoxP3(+) Treg cells is suggested in AMl more than other kinds ofcancer.
21
Increased ABCC4 Expression Induced by ERRα Leads to Docetaxel Resistance via Efflux of Docetaxel in Prostate Cancer.
Houbao Huang,Jing Li,Jing Shen,Ling Lin,Xu Wu,Shixin Xiang,Yawei Li,Yujie Xu,Qijie Zhao,Yueshui Zhao,Parham Jabbarzadeh Kaboli,Mingxing Li,Xiang Li,Weiping Wang,Qinglian Wen,Zhangang Xiao +15 more
TL;DR: A critical role for ERRα in docetaxel resistance is demonstrated by directly targeting ABCC4 and the importance of ERR α as a potential therapeutic target for drug-resistant PCa is stressed.